Sigma Healthcare (ASX:SIG) Moat Score: 4/10 (As of Jul. 01, 2026)


ASX:SIG Sigma Healthcare Ltd ASX:SIG
59 GF Score
Price A$2.74
GF Value A$0.37
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare Moat Score?

Sigma Healthcare ASX:SIG -0.36% 59 Moat Score is 4 as of Jul. 01, 2026. GuruFocus rates ASX:SIG with a GF Score™ of 59/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 119 Medical Distribution companies, Sigma Healthcare ranks better than 89.92% on this metric.

Sigma Healthcare has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Sigma Healthcare has Narrow Moat: Sigma Healthcare has a discernible moat through its distribution network in Australia, offering some cost advantages. However, competitive pressures and limited pricing power constrain its moat to a modest level.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Sigma Healthcare might have Narrow Moat - Discernible but modest moat.

Sigma Healthcare  (ASX:SIG) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Sigma Healthcare Moat Score Related Terms

ASX:SIG vs MCK, CAH, COR: Moat Score Comparison

For the Medical Distribution subindustry, Sigma Healthcare's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sigma Healthcare Moat Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's Moat Score distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's Moat Score falls into.


ASX:SIG
59GF Score
Sigma Healthcare Ltd ASX:SIG
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Sigma Healthcare (ASX:SIG) has a Moat Score of 4 as of Jul. 01, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Sigma Healthcare ranks #12 out of 119 companies in the Medical Distribution industry, placing it in the top 10.1%.
Is Sigma Healthcare's Moat Score too high?
Sigma Healthcare's current Moat Score is 4. Based on the distribution chart, Sigma Healthcare ranks #12 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Sigma Healthcare has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's Moat Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sigma Healthcare ranks #12 out of 119 companies for Moat Score. This places Sigma Healthcare in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Distribution company?
A good Moat Score depends on the Medical Distribution industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Sigma Healthcare's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.74 — trading 640.5% above its estimated fair value. The current Moat Score is 4. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current Moat Score is 4 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of A$2.74 is trading 640.5% above its estimated GF Value™ of A$0.37. GuruFocus considers Sigma Healthcare to be Significantly Overvalued.

Key valuation signals for ASX:SIG:

  • Moat Score: 4
  • GF Value™: A$0.37 vs. price of A$2.74 (640.5% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sigma Healthcare Business Description

Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score

Get the complete analysis for ASX:SIG

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.74
Price
A$0.37
GF Value